203 related articles for article (PubMed ID: 4541349)
21. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
Bartholini G; Blum JE; Pletscher A
J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
[No Abstract] [Full Text] [Related]
22. The effect of L-dopa and an inhibitor of peripheral decarboxylation on glucose metabolism in brain.
Tyce GM
J Neurochem; 1976 Dec; 27(6):1397-403. PubMed ID: 1003214
[No Abstract] [Full Text] [Related]
23. Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.
Bartholini G; Da Prada M; Pletscher A
J Pharm Pharmacol; 1968 Mar; 20(3):228-9. PubMed ID: 4385052
[No Abstract] [Full Text] [Related]
24. Inhibition of a minor pathway of L-dopa metabolism in the intestinal lumen using a decarboxylase inhibitor (Ro 4-4602).
Bakke OM; Scheline RR
J Pharm Pharmacol; 1974 May; 26(5):377-9. PubMed ID: 4152920
[No Abstract] [Full Text] [Related]
25. Brain capillaries as a source of homovanillic acid in cerebrospinal fluid.
Bartholini G; Tissot R; Pletscher A
Brain Res; 1971 Mar; 27(1):163-8. PubMed ID: 5554221
[No Abstract] [Full Text] [Related]
26. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
Butcher LL; Engel J
Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
[No Abstract] [Full Text] [Related]
27. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
Benkert O; Gluba H; Matussek N
Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
[No Abstract] [Full Text] [Related]
28. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
Yoshimine N; Kuzuya F; Mori K; Sakamoto N
Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):566-73. PubMed ID: 732010
[No Abstract] [Full Text] [Related]
29. Central aromatic amines and behavior. III. Correlative analysis of conditioned approach behavior and brain levels of serotonin and catecholamines in monkeys.
Wada JA; McGeer EG
Arch Neurol; 1966 Feb; 14(2):129-42. PubMed ID: 4952437
[No Abstract] [Full Text] [Related]
30. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
Goodale DB; Moore KE
Life Sci; 1976 Sep; 19(5):701-6. PubMed ID: 957902
[No Abstract] [Full Text] [Related]
31. Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.
Kuruma I; Bartholini G; Tissot R; Fletscher A
J Pharm Pharmacol; 1972 Apr; 24(4):289-94. PubMed ID: 4402836
[No Abstract] [Full Text] [Related]
32. Uptake of catecholamines into serotonergic nerve cells as demonstrated by fluorescence histochemistry.
Barrett RE; St Balch T
Experientia; 1971 Jun; 27(6):663-4. PubMed ID: 5556449
[No Abstract] [Full Text] [Related]
33. Chlorpromazine-induced accumulation of pyridoxal-5'-phosphate and activation of the decarboxylase of aromatic amino acids in rat brain.
Gey KF; Burkard WP
Ann N Y Acad Sci; 1969 Sep; 166(1):213-24. PubMed ID: 5308031
[No Abstract] [Full Text] [Related]
34. Monoamine precursors and copulatory behavior in the male rat.
Malmnäs CO
Acta Physiol Scand Suppl; 1973; 400():47-68. PubMed ID: 4546480
[No Abstract] [Full Text] [Related]
35. Differential effect of benserazide on catecholamine concentrations in the rat pineal, cerebral cortex and hypothalamus.
Ho AK; Smith JA
Biochem Pharmacol; 1983 Dec; 32(23):3605-9. PubMed ID: 6651878
[TBL] [Abstract][Full Text] [Related]
36. L-Dopa and imipramine: biochemical and behavioral interaction.
Friedman E; Gershon S
Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
[No Abstract] [Full Text] [Related]
37. Monoamines and the regulation of vigilance and sleep.
Putkonen PT
Med Biol; 1974 Jun; 52(3):193-9. PubMed ID: 4370645
[No Abstract] [Full Text] [Related]
38. Effect of L-dopa on the hypothalamic, pineal and striatal monoamines and on the sexual behaviour of the rat.
Hyyppä M; Lehtinen P; Rinne UK
Brain Res; 1971 Jul; 30(2):265-72. PubMed ID: 5315473
[No Abstract] [Full Text] [Related]
39. Inhibition of tyrosine-3-monooxygenase by benserazide.
Reinhard JF; Shearin MD
Biochem Pharmacol; 1990 May; 39(9):1489-91. PubMed ID: 1970732
[No Abstract] [Full Text] [Related]
40. The influence of L-DOPA perfusion concentrations and peripheral decarboxylase inhibition on dopa accumulation and decarboxylation in isolated perfused rat brains.
Horst WD; Bautz G; Renyi E; Spirt N
Neuropharmacology; 1973 Dec; 12(12):1145-51. PubMed ID: 4782694
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
